Technetium-99m HL91 uptake as a tumour hypoxia marker: Relationship to tumour blood flow

European Journal of Nuclear Medicine

Volumn 26, Issue 2, 1999, Pages 91-94

  Tatsumi, Mitsuaki ^a   Yutani, Kenji ^a   Kusuoka, Hideo ^a   Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Technetium 99m HL91; Tumour blood flow; Tumour hypoxia

Indexed keywords

4,9 DIAZA 3,3,10,10 TETRAMETHYLDODECAN 2,11, DIONE DIOXIME; CARBON 14; IODOPHENAZONE; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG; UPENAZIME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER MODEL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG DISTRIBUTION; FEMALE; HYPOXIA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RAT; TUMOR BLOOD FLOW; TUMOR NECROSIS;

ANIMALS; ANTIPYRINE; AUTORADIOGRAPHY; BLOOD VOLUME; CARBON RADIOISOTOPES; CARCINOMA 256, WALKER; CELL HYPOXIA; FEMALE; NECROSIS; ORGANOTECHNETIUM COMPOUNDS; OXIMES; OXYGEN; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW;

EID: 0033066155     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050364     Document Type: Article

References (11)

1. Chapman JD. Hypoxic sensitizers: implications for radiation therapy. N Engl J Med 1979; 301: 1429-1432.
2. Rasey JS, Koh WJ, Grierson JR, Grunbaum Z, Krohn KA. Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys 1989; 17: 985-991.
3. Ballinger JR, Kee JW, Rauth AM. In vitro and in vivo evaluation of a technetium-99m-labelled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia. J Nucl Med 1996; 37: 1023-1031.
4. Nunn A, Linder K, Strauss HW. Nitroimidazoles and imaging hypoxia. Eur J Nucl Med 1995; 22: 265-280.
5. Archer CM, Edwards B, Kelly JD, King AC, Burke JF, Riley ALM. Technetium labelled agents for imaging tissue hypoxia in vivo. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and rhenium in chemistry and nuclear medicine. Padova: SGE Ditoriali; 1995: 535-539.
6. 99mTc-HL91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent. Circulation 1997; 95: 1892-1899.
7. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998; 58: 1408-1416.
8. Thomlinson RH, Gray LH. The histological structure of some human lung cancer and the possible implications for radiotherapy. Br J Cancer 1955; 9: 539-549.
9. 14C]antipyrine. Am J Physiol 1978; 234: H59-H66.
10. 99mTc-HL91. "Hot spot" detection of ischemic myocardium in vivo by gamma camera imaging. Circulation 1998; 97: 2557-2566.
11. Brown JM. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 1979; 52: 650-656.